Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286181 · ClinicalTrials.gov registry record · NA
Device-guided Breathing for Shortness of Breath in COPD
A NA study of COPD and Dyspnea, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01286181: Completed NA study of COPD and Dyspnea, sponsored by Mayo Clinic.
NCT01286181 is a NA study of COPD and Dyspnea that has completed, run by Mayo Clinic. The registered enrollment target is 11 participants, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286181, a NA study of COPD and Dyspnea, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Although drug therapies and pulmonary rehabilitation have greatly improved COPD symptoms, as many as 50% of patients with severe COPD have inadequately controlled dyspnea. Device-guided breathing is a behavioral intervention that guides respiratory rates into a therapeutic range; prolongation of the expiratory phase improves hyperinflation, the most significant driver of dyspnea in this population. Device-guided breathing, has no known side-effects, and may represent a cost effective adjunctive treatment for dyspnea in severe COPD.
Primary Outcome
Pre and post device use measures of dyspnea, health-related quality of life, stress, adn self-efficacy for managing chronic disease will be obtained through self-administered questionnaires.
Conditions Studied
Interventions
- BEHAVIORAL Twice daily practice of device-guided slow breathing.
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01286181 record still lists
NCT01286181 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 2,418-participant average among 85 other COPD trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Twice daily practice of device-guided slow breathing. is the first listed.
NCT01286181 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01286181 about?
NCT01286181 is a clinical study titled "Device-guided Breathing for Shortness of Breath in COPD". Although drug therapies and pulmonary rehabilitation have greatly improved COPD symptoms, as many as 50% of patients with severe COPD have inadequately controlled dyspnea. Device-guided breathing is a behavioral intervention that guides respiratory rates into a therapeutic range; prolongation of the...
What is the current status of trial NCT01286181?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2011-01. Estimated completion is 2011-12.
What conditions does trial NCT01286181 study?
This clinical trial studies the following conditions: COPD, Dyspnea, Hyperinflation.
What interventions are being tested in trial NCT01286181?
The interventions under investigation include: Twice daily practice of device-guided slow breathing. (BEHAVIORAL).
Who is sponsoring clinical trial NCT01286181?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01286181 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01286181's enrollment target sits among peer trials
11 83rd of 85 higher than 3 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
The Reducing REVISITS Study: A Cluster RCT
RECRUITING · NA
-
The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
RECRUITING · NA
-
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia